Wednesday 2 December 2020 11:26 PM UTC
BRUSSELS Dec 3: EU officials claimed on Wednesday that the block was not delayed in the race to deploy the coronavirus vaccine. Former member Britain has approved what Europe is still evaluating.
The British minister claimed that Brexit allowed the Pfizer-BioNTech vaccine to be adopted ahead of neighbors who were still waiting for a green light from the European Medicines Agency (EMA).
The UK, which is under EU drug marketing regulations until December 31, the end of the post-Brexit transition period, approves vaccines under the urgent provisions of European law.
Despite concerns from Brussels, Hungary began receiving samples of the Russian Sputnik V vaccine, but most European Union countries did not take this course and preferred to wait for the EMA.
British Health Minister Matt Hancock told Times Radio that the UK “will not keep pace with the slow-moving Europeans,” thanks to leaving EMA.
The EMA was in London until last year, but moved to Amsterdam as part of a slow divorce from the European Union in the United Kingdom. Today, it is studying several potential COVID-19 vaccines.
Germany’s Health Minister Jens Spahn spoke at a video conference with a colleague in the EU, saying, “The idea is not the first, but a safe and efficient vaccination.”
Spahn, who is taking turns hosting the EU Presidency, said authorities would meet with the EMA on December 11 to assess progress before deciding which of the competing vaccines to approve.
“It’s clearly a matter of expertise, but as you can see from comments from Britain, it’s also a political issue of the European Union,” he admitted.
“It should be noted that there are different procedures and different approaches to the UK and European Union issues, and that the US and UK today are based on urgent and prompt approval,” he said.
“In that respect, we prefer to have conditional procedures on a regular basis and use trial-and-error procedures that can lead to timing differences.”
EU Health Commissioner Stella Kyriakides said it is important to follow steps and explain clearly in order for the general public to trust the vaccine.
“It’s also important to convey these messages to the public, as they need to be confident and able to move forward and be vaccinated. We emphasize this many times,” she said. Said.
US giant Pfizer and its German partner BioNTech, one of the six teams with which the EU has a final vaccine supply contract, have submitted test data to the EMA.
Authorities have announced that they will decide to approve at or before the December 29 meeting.
Follow the latest news about the outbreak of coronavirus (COVID-19)
CLICK TO FOLLOW UKMALAYALEE.COM